The 2017 Kidney Disease: Improving Global Outcomes (KDIGO) guideline on the management of chronic kidney disease-mineral bone disorder (CKD-MBD) suggests measuring serum calcium and serum phosphate every one to three months and serum parathyroid hormone (PTH) every three to six months. This evidence concerns the gene PTH and kidney disorder.